Sort
8,912 grants matching “sars cov 2”
Characteristics of COVID-19 in transgender people
$208,032Michael Goodman · Emory University · R01 · FY2023 · AG
Impact of mucosal adjuvanted vaccines on virus transmission in preclinical animal models for SARS-CoV-2 and influenza virus infection
$208,000Michael Schotsaert · Icahn School Of Medicine At Mount Sinai · R21 · FY2025 · AI
SARS-CoV-2 polymerase inhibitor screening
$207,993Baek Kim · Emory University · R01 · FY2020 · AI
Evaluating Clinical and Immunological Consequences of SARS-CoV-2 Vaccination in Rheumatic Disease
$207,958Robyn Therese Domsic · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · AR
Louisiana Clinical and Translational Science Center - N3C supplement
$207,884John P. Kirwan · Lsu Pennington Biomedical Research Ctr · U54 · FY2022 · GM
Nasal RNA response to respiratory viral infections
$207,875Tao Pan · University Of Chicago · R21 · FY2023 · AI
Administrative Supplement to R21: Mechanism and in vivo activity of novel glycan-based therapy against flavivirus endothelial permeability and vascular leak
$207,743Eva Harris · University Of California Berkeley · R21 · FY2021 · AI
Integrated Network Analysis of RADx-UP Data to Increase COVID-19 Testing and Vaccination Among Persons Involved with Criminal Legal Systems (PCLS)
$207,669Aditya Subhash Khanna · Brown University · R21 · FY2024 · MD
Biological Sequence Quality Control and Organization
$207,502Eric Nawrocki · National Library Of Medicine · ZIB · FY2023 · LM
The impact of the COVID-19 pandemic on adolescent drinking in a longitudinal cohort spanning 21 U.S. cities
$207,471William Ellerbe Pelham III · University Of California, San Diego · R21 · FY2022 · AA
BIOREPOSITORY OPTIMIZATION AND USE FOR ENDOTYPING CRITICALLY ILL SARS-COV-2 INFECTED PATIENTS
$207,405Leopoldo Nicolas Segal · New York University School Of Medicine · R21 · FY2023 · GM
Rapid measurement of novel harm reduction housing on HIV risk, treatment uptake, drug use and supply
$207,369Traci C Green · Brandeis University · R21 · FY2024 · DA
mRNA-Based Vaccines Against Tick Borne Thogotoviruses
$207,262Adrianus Cm Boon · Washington University · R21 · FY2025 · AI
SARS-CoV-2 Clinical Cohort Core
$207,212Dahlene Nicole Fusco · Tulane University Of Louisiana · U54 · FY2022 · CA
Microbiota-Mediated Bidirectional Interactions Between Alcohol Misuse and Post-COVID-19 Syndrome
$207,052Ali Keshavarzian · Rush University Medical Center · R01 · FY2023 · AA
NSF Postdoctoral Fellowship in Biology: Evolution of Increased Parasite Transmission Dispersion
$207,000Hannelore A Macdonald · Macdonald, Hannelore A · · FY2022 · BIO
Potential role of skin in SARS-CoV-2 infection
$206,917Irina V Budunova · Northwestern University At Chicago · R21 · FY2024 · AI
Statistical Methods and Algorithms for Population Genomic Inference
$206,764Bruce Rannala · University Of California At Davis · R01 · FY2020 · GM
Assessment of Zoonotic Risk of Emerging Infections in Companion Animals
$206,717Laura Brunengraber Goodman · Cornell University · U18 · FY2023 · FD
Regulation of early life immunity by maternal microchimeric cells
$206,600Nitya Jain · Massachusetts General Hospital · R21 · FY2022 · AI
Task B25: In Vitro Assessment for Antimicrobial Activity Against Respiratory Viruses, SARS-CoV-2
$206,532Brett Hurst · Utah State University · N01 · FY2024 · AI
SUBPOPULATIONS AND INTERMEDIATE OUTCOMES IN COPD (SPIROMICS) III - TASK AREA B
$206,351Erica Anderson · · N01 · FY2024 · HL
The Role of alternative mRNA polyadenylation in SARS-CoV-2 replication & the host response
$206,250Claire L Moore · Tufts University Boston · R21 · FY2022 · AI
Digital pathology for defining myeloid cell-mediated lung injury during acute SARS CoV-2 Infection in hamsters
$206,250Amanda Martinot · Tufts University Boston · R21 · FY2023 · AI
Mentoring translational researchers in perinatal infectious diseases
$205,999Stephanie Lina Gaw · University Of California, San Francisco · K24 · FY2025 · AI